Abstract
A bioactivity-guided fractionation of an extract of Terminalia bellerica fruit rind led to the isolation of two new lignans named termilignan (1) and thannilignan (2), together with 7-hydroxy-3',4'-(methylenedioxy)flavan (3) and anolignan B (4). All four compounds possessed demonstrable anti-HIV-1, antimalarial, and antifungal activity in vitro.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / isolation & purification*
-
Anti-HIV Agents / pharmacology
-
Antifungal Agents / chemistry
-
Antifungal Agents / isolation & purification*
-
Antifungal Agents / pharmacology
-
Antimalarials / chemistry
-
Antimalarials / isolation & purification*
-
Antimalarials / pharmacology
-
Flavonoids / chemistry
-
Flavonoids / isolation & purification
-
Flavonoids / pharmacology
-
Lignans / chemistry
-
Lignans / isolation & purification
-
Magnetic Resonance Spectroscopy
-
Plants, Medicinal / chemistry*
Substances
-
7-hydroxy-3',4'-(methylenedioxy)flavan
-
Anti-HIV Agents
-
Antifungal Agents
-
Antimalarials
-
Flavonoids
-
Lignans